Article
Black Raspberry Extract and Fractions Contain Angiogenesis Inhibitors
19 Apr 2005
Abstract excerpt
Targeted therapies, such as agents that inhibit angiogenesis, offer hope as complementary agents in cancer therapy. Angiogenesis-inhibiting agents have the potential for inhibiting tumor growth and limiting the dissemination of metastasis, thus keeping cancers in a static growth state for prolonged periods. Black raspberry (Rubus occidentalis) extract was discovered to be antiangiogenic (0.1% w/v) in a novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
